Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beta Drugs Limited has informed the NSE that it published its audited financial results for Q4 FY2026 and the full financial year ended 31 March 2026 in newspapers (Business Standard in English and Hindi) on 16 May 2026. The Board of Directors had approved these results at their meeting held on 15 May 2026. The full results along with the Auditor's Report have been posted on the company's website and are accessible via QR code. The company states the results are prepared in accordance with Indian Accounting Standards as required under the Companies Act, 2013 and SEBI regulations. This is a mandatory compliance filing confirming that quarterly and annual financial performance has been publicly disclosed.
This is a routine regulatory filing confirming public disclosure of financial results. It has no direct impact on the stock price but ensures transparency and compliance with listing obligations. Shareholders should refer to the full results on the company website for detailed performance analysis.